Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Eltrombopag for Enhancement of Platelet Engraftment in Patients Undergoing Allogeneic Cord Blood Transplantation

Oren Pasvolsky, Liat Shargian, MD, Uri Rozovski, Ron Ram, MD, Michael Y. Shapira, MD, Moshe Israeli, Liat Vidal-Fisher, MD MSc, Ofer Shpilberg, MD MPH, Pia Raanani, Moshe Yeshurun

Blood (2018) 132 (Supplement 1): 2092.

https://doi.org/10.1182/blood-2018-99-116048

Published: 2018

Journal Articles

Regional Intra-Arterial Steroid Treatment in 113 Patients with Steroid Resistant or Dependent Graft-Versus-Host Disease

Michael Y Shapira, MD, Sheth Vipul, MD, Alexander Klimov, Sigal Griesaro, MD, Panagiotis Tsirigotis, MD PhD, Batia Ronit Avni, MD, Reuven Or, Allan Bloom, MD

Blood (2016) 128 (22): 62.

https://doi.org/10.1182/blood.V128.22.62.62

Published: 2016

Journal Articles

Long Term Update on Phase I/II Trial with Immucin Anti-MUC1 Signal Peptide Vaccine for Multiple Myeloma Patients with Residual Disease or Progression

Lior Carmon, PhD, Irit Avivi, Riva Kovjazin, Lillian Dary, Michael Y Shapira, MD

Blood (2014) 124 (21): 4768.

https://doi.org/10.1182/blood.V124.21.4768.4768

Published: 2014

Journal Articles

Incidence and Risk Factors For Veno-Occlusive Disease Of The Liver After Allogeneic Stem Cell Transplantation Using a Reduced Intensity Regimen

Panagiotis Tsirigotis, Igor B Resnick, Batia Ronit Avni, M.D., Sigal Grisariu, MD, Polina Stepensky, Reuven Or, MD, Michael Y Shapira, MD

Blood (2013) 122 (21): 4562.

https://doi.org/10.1182/blood.V122.21.4562.4562

Published: 2013

Journal Articles

Phase I/II Trial Of Immucin a Pan HLA, Anti-MUC1 Signal Peptide Vaccine, In Multiple Myeloma Patients With Residual Disease Or Progression Following Autologous Stem Cell Transplantation

Lior Carmon, PhD, Irit Avivi, MD, Kovjazin Riva, MD, Lillian Dary, Michael Y Shapira, MD

Blood (2013) 122 (21): 1943.

https://doi.org/10.1182/blood.V122.21.1943.1943

Published: 2013

Journal Articles

Correction of Post-Transplant Hematopoiesis by Novel Use of Mesenchymal-Like Placental Expanded Cells (PLX) Administered Intra-Muscular

Reuven Or, MD, Sigal Grisaro, M.D., Batia Ronit Avni, M.D., Igor Resnick, M.D. PhD, Lilyan Dari, David Shoshani, M.D., Dalia Bracha, RN, MPA, Nurit Beilin, DVM, Limor Lior, MSc, Michael Y. Shapira, MD

Blood (2012) 120 (21): 4133.

https://doi.org/10.1182/blood.V120.21.4133.4133

Published: 2012

Journal Articles

Treatment of Severe Acute Graft-Versus-Host Disease with Mesenchymal Stromal Cells.

Igor B Resnick, Jr., MD, PhD, DSci, Polina Stepensky, MD, Michael Y. Shapira, MD, Claudine Barkatz, MSc, Gregory Elkin, PhD, Olga Gurevich, PhD, Avichai Shimoni, MD, Nira Varda-Bloom, PhD, Moshe Yeshurun, MD, Amos Toren, Sr., MD, PhD, Tsila Zukerman, MD, Michael Weintraub, Sr., MD, Arnon Nagler, MD, Reuven Or, MD

Blood (2009) 114 (22): 2249.

https://doi.org/10.1182/blood.V114.22.2249.2249

Published: 2009

Journal Articles

The Optimal Initiation Timing for Cyclosporine in Allogeneic Transplantation, Earlier Is Better with the Price of Higher Rate of Chronic Gvhd.

Liliane Dray, Aliza Matusevich, Igor Resnick, Memet Aker, M.D, Simcha Samuel, Reuven Or, Michael Y. Shapira, MD

Blood (2009) 114 (22): 1143.

https://doi.org/10.1182/blood.V114.22.1143.1143

Published: 2009

Journal Articles

Alefacept Treatment for Graft Vs. Host Disease May Not Suppress the Graft Vs. Leukemia Effect.

Liliane Dray, Aliza Matusevich, Igor Resnick, Memet Aker, M.D, Polina Stepansky, Reuven Or, Michael Y. Shapira, MD

Blood (2009) 114 (22): 2223.

https://doi.org/10.1182/blood.V114.22.2223.2223

Published: 2009

Journal Articles

Ex-Vivo UVA Treated Donor T-Cells for the Induction of Graft Versus Leukemia Effect in Murine Model and Clinical Application

Si mcha Samuel, Lola Weiss, Osnat Hazan, Igor B Resnick, Michael Y. Shapira, MD, Benjamin Gesundheit, Lilane Dray, Reuven Or

Blood (2008) 112 (11): 4618.

https://doi.org/10.1182/blood.V112.11.4618.4618

Published: 2008

Journal Articles

The Rate of Cytomegalovirus Infection and Disease in Correlation with the Type of Hematopoietic Stem Cell Transplantation in the Era of Preemptive Antiviral Therapy

Benjamin Gesundheit, Reuven Or, Einat Budowski, Michael Y. Shapira, MD, Igor B. Resnick, Simcha Samuel, Liliane Dray, Orit Kaplan, Dana Wolf

Blood (2008) 112 (11): 4347.

https://doi.org/10.1182/blood.V112.11.4347.4347

Published: 2008

Journal Articles

Intra-Arterial Catheter Directed Immunosuppressive Therapy for Steroid Resistant or Dependent Graft vs. Host Disease (GVHD).

Michael Y. Shapira, MD, Allan I. Bloom, MD, Reuven Or, MD, Igor B. Resnick, MD, PhD, DSc, Memet Aker, MD, Shimon Slavin, MD, Anthony Verstandig, MD

Blood (2007) 110 (11): 4960.

https://doi.org/10.1182/blood.V110.11.4960.4960

Published: 2007

Journal Articles

Simultaneous Haploidentically Mismatched Stem Cell Transplantation from Multi-Donors (MDT) in Humans Offers Better Engraftment as Compared to Single Haploidentical Donor.

Michael Y. Shapira, MD, Igor B. Resnick, MD DSc PhD, Benjamin Gesundeheidt, MD PhD, Simcha Samuel, MSc, Liliane Drey, RN, Yuri Verkholevsky, RN BA, Shimon Slavin, MD, Reuven Or, MD

Blood (2007) 110 (11): 4854.

https://doi.org/10.1182/blood.V110.11.4854.4854

Published: 2007

Journal Articles

Thymoglobulin ® Rabbit Anti-Thymocyte Globulins (r-ATG) Induces Faster Platelet Recovery and Does Not Suppress Granulocyte Engraftment in a Non-Myeloablative Stem Cell Transplantation Setting.

Michael Y. Shapira, MD, Igor B. Resnick, MD PhD DSc, Benjamin Gesundeheidt, MD PhD, Menachem Bitan, Aliza Ackerstein, MSc, Simcha Samuel, MSc, Liliane Drey, RN BA, Yuri Verkholevsky, RN BA, Shimon Slavin, MD, Reuven Or, MD

Blood (2007) 110 (11): 4942.

https://doi.org/10.1182/blood.V110.11.4942.4942

Published: 2007

Journal Articles

Transplantation from Related and Unrelated Donors in Elderly Patients - Equal Toxicity and Survival.

Michael Y. Shapira, MD, Panagiotis D. Tsirigotis, MD PhD, Reuven Or, MD, Igor B. Resnick, MD PhD, Menachem Bitan, MD, Benjamin Gesundheit, MD PhD, Shimon Slavin

Blood (2006) 108 (11): 5256.

https://doi.org/10.1182/blood.V108.11.5256.5256

Published: 2006

Journal Articles

N-Acetylcysteine Mildly Inhibits the Graft vs Leukemia Effect but Not the Lymphokine Activated Cells (LAK) Activity.

Michael Y. Shapira, MD, Lola Weiss, PhD, Shoshana Reich, Michael Zeira, PhD, Shimon Slavin, MD

Blood (2006) 108 (11): 5171.

https://doi.org/10.1182/blood.V108.11.5171.5171

Published: 2006

Journal Articles

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia.

Michael Y. Shapira, MD, Tsirigotis D. Panagiotis, MD PhD, Reuven Or, MD, Igor B. Resnick, MD PhD, Benjamin Gesundheit, MD, Shimon Slavin, MD

Blood (2006) 108 (11): 3038.

https://doi.org/10.1182/blood.V108.11.3038.3038

Published: 2006

Journal Articles

Assessment of the Immune Reconstitution by Cylex Immuknow™ Assay in Patients after Allogeneic Stem Cell Transplantation.

Benjamin Gesundheit, MD, PhD, Yehudit Azar, PhD, Rachel Bringer, BSc, Schivti Steinberg-Prop, MSc, Moshe Israeli, BSc, Michael Y. Shapira, MD, Igor Resnick, MD, Simcha Samuel, MSc, Shimon Slavin, MD, Reuven Or, MD

Blood (2006) 108 (11): 3219.

https://doi.org/10.1182/blood.V108.11.3219.3219

Published: 2006

Journal Articles

Enhancement of Hematopoietic Stem Cell Engraftment and Graft vs. Leukemia Effect Induced by Matched and Haploidentically Mismatched Allograft Using Multi-Donor Stem Cell Transplantation (MDT).

Michael Y. Shapira, MD, Reuven Or, MD, Igor B. Resnick, MD PhD, Simcha Samuel, MSc, Benjamin Gesundheit, MD PhD, Shimon Slavin, MD

Blood (2006) 108 (11): 3663.

https://doi.org/10.1182/blood.V108.11.3663.3663

Published: 2006

Journal Articles

Amplification of Graft vs Malignancy (GVM) Effects by Using Intentionally Mismatched Donor Lymphocytes While Avoiding Graft-vs-Host Disease in Conjunction with Haploidentically Mismatched Stem Cell Allografts in Patients with Hematological Malignances.

Shimon Slavin, MD, Michael Y. Shapira, MD, Igor B. Resnick, MD, Menachem Bitan, MD, Memet Aker, MD, Simcha Samuel, MSc, Shoshana Morecki, PhD, Reuven Or, MD

Blood (2006) 108 (11): 5157.

https://doi.org/10.1182/blood.V108.11.5157.5157

Published: 2006

NARROW

Eltrombopag for Enhancement of Platelet Engraftment in Patients Undergoing Allogeneic Cord Blood Transplantation

Regional Intra-Arterial Steroid Treatment in 113 Patients with Steroid Resistant or Dependent Graft-Versus-Host Disease

Long Term Update on Phase I/II Trial with Immucin Anti-MUC1 Signal Peptide Vaccine for Multiple Myeloma Patients with Residual Disease or Progression

Incidence and Risk Factors For Veno-Occlusive Disease Of The Liver After Allogeneic Stem Cell Transplantation Using a Reduced Intensity Regimen

Phase I/II Trial Of Immucin a Pan HLA, Anti-MUC1 Signal Peptide Vaccine, In Multiple Myeloma Patients With Residual Disease Or Progression Following Autologous Stem Cell Transplantation

Correction of Post-Transplant Hematopoiesis by Novel Use of Mesenchymal-Like Placental Expanded Cells (PLX) Administered Intra-Muscular

Treatment of Severe Acute Graft-Versus-Host Disease with Mesenchymal Stromal Cells.

The Optimal Initiation Timing for Cyclosporine in Allogeneic Transplantation, Earlier Is Better with the Price of Higher Rate of Chronic Gvhd.

Alefacept Treatment for Graft Vs. Host Disease May Not Suppress the Graft Vs. Leukemia Effect.

Ex-Vivo UVA Treated Donor T-Cells for the Induction of Graft Versus Leukemia Effect in Murine Model and Clinical Application

The Rate of Cytomegalovirus Infection and Disease in Correlation with the Type of Hematopoietic Stem Cell Transplantation in the Era of Preemptive Antiviral Therapy

Intra-Arterial Catheter Directed Immunosuppressive Therapy for Steroid Resistant or Dependent Graft vs. Host Disease (GVHD).

Simultaneous Haploidentically Mismatched Stem Cell Transplantation from Multi-Donors (MDT) in Humans Offers Better Engraftment as Compared to Single Haploidentical Donor.

Thymoglobulin ® Rabbit Anti-Thymocyte Globulins (r-ATG) Induces Faster Platelet Recovery and Does Not Suppress Granulocyte Engraftment in a Non-Myeloablative Stem Cell Transplantation Setting.

Transplantation from Related and Unrelated Donors in Elderly Patients - Equal Toxicity and Survival.

N-Acetylcysteine Mildly Inhibits the Graft vs Leukemia Effect but Not the Lymphokine Activated Cells (LAK) Activity.

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia.

Assessment of the Immune Reconstitution by Cylex Immuknow™ Assay in Patients after Allogeneic Stem Cell Transplantation.

Enhancement of Hematopoietic Stem Cell Engraftment and Graft vs. Leukemia Effect Induced by Matched and Haploidentically Mismatched Allograft Using Multi-Donor Stem Cell Transplantation (MDT).

Amplification of Graft vs Malignancy (GVM) Effects by Using Intentionally Mismatched Donor Lymphocytes While Avoiding Graft-vs-Host Disease in Conjunction with Haploidentically Mismatched Stem Cell Allografts in Patients with Hematological Malignances.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only